查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404815

肝病诊断市场规模、份额、趋势分析报告：按诊断技术、最终用途、地区、细分市场预测，2023-2030 年

Liver Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy, Others), By End-use (Hospitals, Laboratories, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

肝病诊断市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，预计 2030 年全球肝病诊断市场规模将达到 586.2 亿美元，2023 年至 2030 年复合年增长率为 6.5%。

市场参与者采取的资金筹措和研究倡议的增加是预计推动市场成长的主要因素之一。例如，2019年11月，Glycotest, Inc.获得上海復星医药股份有限公司（復星医药）第二笔300万美元1000万美元A轮资金筹措。透过这项投资， Glico将把其肝癌组合技术转移给佛山医药，在中国进行商业化，并开发目前正在研发中的肝癌和肝纤维化测试。

公司正专注于合作研究和合作伙伴关係，以提高医疗保健质量，预计这将推动市场发展。例如，2019 年 10 月，Perspectum Diagnostics 建立合作伙伴关係，在新加坡 Precious 医疗中心提供 LiverMultiScan。此次合作的目的是提高人们的认识，将肝臟检查作为健康检查的一个组成部分。

支持开发能够准确区分良性和恶性病变的新诊断方法的研究和开发预计将推动市场成长。例如，柏林 Charite-Universitatsmedizin 的研究人员使用断层弹性成像技术可视化肿瘤的机械特性，并使用新的磁振造影(MRI) 技术来检测肿瘤的一致性分级。

此外，该公司还进行临床试验以开发具有高灵敏度和特异性的新测试。例如，高级医学研究所正在进行一项临床试验，对 1,600 名超音波患者进行侵入性切片检查与 cfDNA 甲基化定量与超音波检查进行比较。此次检查预计2020年完成。

准确诊断的开拓和商业化预计将推动市场发展。例如，2020 年 3 月，ENDRA Life Sciences Inc. 的 TAEUS FLIP 系统获得了 CE 标誌。此系统测量肝臟脂肪，以识别和监测非酒精性脂肪肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH)。一种可在护理点准确量化肝臟脂肪的超音波系统。

肝病诊断市场报告亮点

  • 诊断成像领域占据最大的收益占有率份额，预计将以最快的复合年增长率成长。这是由于肝病诊断市场的主要企业采取了一系列倡议来开发先进的诊断影像技术。
  • 到 2022 年，医院部门将占据最大的销售份额，约为 45%，因为大多数患者都使用拥有设备齐全的诊断测试设备的医院。
  • 北美将主导市场，到 2022 年将占据最大的销售份额，超过 40%，其次是欧洲。研发的高投资和主要参与者的存在预计将成为推动该地区肝病诊断市场成长的因素。
  • 预计亚太地区在预测期内将以 8.6% 的复合年增长率增长最快。老年人口的增加和对定期检查的认识正在促进该地区肝病诊断市场的成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章肝病诊断市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 肝病诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章 肝病诊断：诊断技术评估及趋势分析

  • 肝病诊断市场：要点
  • 肝病诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 影像
  • 临床检查
  • 内视镜检查
  • 切片检查
  • 其他的

第五章肝病诊断：最终用途估计与趋势分析

  • 肝病诊断市场：要点
  • 肝病诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
  • 实验室
  • 其他的

第六章 肝病诊断市场：区域估算及趋势分析

  • 区域展望
  • 按地区分類的肝病诊断市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Randox Laboratories Ltd.
    • Boston Scientific Corporation
    • Laboratory Corporation of America Holdings
    • Fujifilm Corporation
    • Horiba Medical
    • Siemens Healthcare GmbH
Product Code: GVR-4-68038-693-6

Liver Disease Diagnostics Market Growth & Trends:

The global liver disease diagnostics market size is expected to reach USD 58.62 billion by 2030, expanding at a CAGR of 6.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. increasing funding and research initiatives undertaken by market players is one of the major factors expected to propel market growth. For instance, in November 2019, Glycotest, Inc. received the second USD 3.0 million tranche of USD 10.0 million Series A funding from Shanghai Fosun Pharmaceutical Co., Ltd.(Fosun Pharma). Under this investment, Glycotest, Inc. transferred HCC panel technology to Fosun Pharma to commercialize in China and develop tests for liver cancer and liver fibrosis that are currently under pipeline.

Companies are focusing on collaborations and partnership to improve the quality of care,which is anticipated to drive the market. For instance, in October 2019, Perspectum Diagnostics entered into a partnership to offer LiverMultiScan at Precious Medical Center in Singapore. The aim of this partnership was to create awareness among people to consider liver checking as an integral part of their health screening.

Researchers conducting studies to support the development of novel diagnostic methods that can accurately differentiate between benign and malignant lesions are expected to fuel market growth. For instance, researchers from Charite - Universitatsmedizin Berlin used tomoelastography to visualize mechanical properties of tumors and developed a new Magnetic Resonance Imaging (MRI) technique to detect grading of tumor consistency.

Furthermore, companies are conducting clinical trials to develop new tests with high sensitivity and specificity. For instance, Laboratory for Advanced Medicine is conducting a clinical trial on 1,600 patients with liver cirrhosis using invasive biopsy through quantification of cfDNA methylation and comparing it with ultrasound technique. The test is projected to be completed in 2020.

Development and commercialization of accurate diagnostic methods is expected to boost the market. For instance, in March 2020, ENDRA Life Sciences Inc. received CE mark for TAEUS FLIP system. This system measures liver fat to identify and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). It is an ultrasound system that accurately and at point of care quantifies fat in the liver.

Liver Disease Diagnostics Market Report Highlights:

  • The imaging segment accounted for the largest revenue share and is expected to grow at the fastest CAGR. This is attributed to the rising number of initiatives taken by key players in the liver disease diagnostics market to develop advanced imaging techniques.
  • The hospitals segment held the largest revenue share of around 45% in 2022 as the majority of patients rely on hospitals well-equipped with diagnostic testing devices.
  • North America dominated the market and accounted for the largest revenue share of over 40% in 2022 followed by Europe. High investments in R&D and the presence of key players are some factors expected to be responsible for the growth of the market for liver disease diagnostics in the region.
  • Asia Pacific is expected to grow at the fastest CAGR of 8.6% during the forecast period. Increasing geriatric population and awareness about regular check-ups are contributing to the growth of the market for liver disease diagnostics in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Diagnosis technique
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Diagnosis technique
    • 2.2.2. End use
    • 2.2.3. Regional scope
  • 2.3. Competitive Insights

Chapter 3. Liver Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Liver Disease Diagnostics Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Liver Disease Diagnostics: Diagnosis Technique Estimates & Trend Analysis

  • 4.1. Liver Disease Diagnostics Market: Key Takeaways
  • 4.2. Liver Disease Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Imaging
    • 4.3.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Laboratory Tests
    • 4.4.1. Laboratory tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Endoscopy
    • 4.5.1. Endoscopy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Biopsy
    • 4.6.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Liver Disease Diagnostics: End Use Estimates & Trend Analysis

  • 5.1. Liver Disease Diagnostics Market: Key Takeaways
  • 5.2. Liver Disease Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Laboratories
    • 5.4.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Liver Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Liver Disease Diagnostics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. F. Hoffmann-La Roche Ltd.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Thermo Fisher Scientific Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Randox Laboratories Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Boston Scientific Corporation
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Laboratory Corporation of America Holdings
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Fujifilm Corporation
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Horiba Medical
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Siemens Healthcare GmbH
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 3 North America liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 6 U.S. liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 8 Canada liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 10 Europe liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 13 Germany liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 15 UK liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 17 France liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 19 Italy liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 21 Spain liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 23 Sweden liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 25 Norway liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 27 Denmark liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 China liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 32 China liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 34 Japan liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 36 India liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 38 Australia liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 40 Thailand liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 42 South Korea liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 44 Latin America liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 47 Brazil liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 49 Mexico liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 51 Argentina liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 56 South Africa liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 60 UAE liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 62 Kuwait liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Liver disease diagnostics: Market outlook
  • Fig. 9 Liver disease diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Liver disease diagnostics market driver impact
  • Fig. 15 Liver disease diagnostics market restraint impact
  • Fig. 16 Liver disease diagnostics market strategic initiatives analysis
  • Fig. 17 Liver disease diagnostics market: Diagnosis technique movement analysis
  • Fig. 18 Liver disease diagnostics market: Diagnosis technique outlook and key takeaways
  • Fig. 19 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Laboratory tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Endoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Liver disease diagnostics market: End use movement analysis
  • Fig. 25 Liver disease diagnostics market: End use outlook and key takeaways
  • Fig. 26 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Global liver disease diagnostics market: Regional movement analysis
  • Fig. 30 Global liver disease diagnostics market: Regional outlook and key takeaways
  • Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)